Trellus Health plc (AIM:TRLS)

Market Cap	1.05M
Revenue (ttm)	91.06K
Net Income (ttm)	-6.22M
Shares Out	161.51M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	140,469
Average Volume	241,157
Open	0.6375
Previous Close	0.6500
Day's Range	0.5000 - 0.6500
52-Week Range	0.5000 - 5.4000
Beta	2.12
RSI	34.83
Earnings Date	Sep 26, 2025

About Trellus Health

Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a proprietary HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease (IBD), including Crohn's Disease and ulcerative colitis. The company was incorporated in 2020 and is headquartered in White Plains, New York.

• Industry: Medical - Healthcare Information Services
• Sector: Healthcare
• Founded: 2020
• Employees: 19
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TRLS

Financial Performance

In 2024, Trellus Health's revenue was $114,000, an increase of 500.00% compared to the previous year's $19,000. Losses were -$7.78 million, 22.8% more than in 2023.

Financial numbers in USD